Results 41 to 50 of about 5,103,286 (236)
Reanalyzing Head et al. (2015): investigating the robustness of widespread p-hacking [PDF]
PeerJ, 2017 Head et al. (2015) provided a large collection of p-values that, from their perspective, indicates widespread statistical significance seeking (i.e., p-hacking). This paper inspects this result for robustness.
Chris H.J. Hartgerink
doaj +2 more sources
International Statistical Review, 2006 SummaryThis paper generalizes the notion of p‐value to obtain a system for assessing evidence in favor of an hypothesis. It is not quite a quantification in that evidence is a pair of numbers (the p‐value and the p‐value with null and alternative interchanged) with evidence for the alternative being claimed when the first number is small and the second
openaire +2 more sources
Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya +10 more
wiley +1 more source
The psychological reality of the learned “p < .05” boundary
Cognitive ResearchThe .05 boundary within Null Hypothesis Statistical Testing (NHST) “has made a lot of people very angry and been widely regarded as a bad move” (to quote Douglas Adams).
V. N. Vimal Rao +2 more
doaj +1 more source
Editorial: P-values, theory, replicability, and rigour
Demographic Research, 2019 Background: In the light of the recent discussions about the statistical rigour of empirical research, including the interpretation and use of p-values and the importance of the theoretical underpinnings of population studies, the editorial board of ...
Jakub Bijak
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro +10 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman +17 more
wiley +1 more source
pvclass: An R Package for p Values for Classification
Journal of Statistical Software, 2017 Let (X, Y) be a random variable consisting of an observed feature vector X and an unobserved class label Y ∈ {1, 2, . . . , L} with unknown joint distribution.
Niki Zumbrunnen, Lutz Dümbgen
doaj +1 more source
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy +5 more
wiley +1 more source